Recombinant Human HLA-A*0201 NY-ESO-1 (SLLMWITQC) complex protein, His-Avi-tagged, Biotinylated

Specification :
| Description : NY-ESO-1 is a human tumor antigen of the cancer/testis family. It is highly expressed in many poor-prognosis melanomas. The Human HLA-A*0201 NY-ESO-1 (SLLMWITQC) complex Protein is a complex of HLA-A*0201 of the MHC Class I, B2M and SLLMWITQC peptide of the NY-ESO-1. | Source : HEK293 | Species : Human | Tag : His-Avi | Form : Supplied as 0. 22um filtered solution in PBS (pH 7. 4). | Molecular Mass : Human HLA-A*0201 NY-ESO-1 (SLLMWITQC) complex Protein has a predicted MW of 50. 5kDa. The protein migrates to 50-60 kDa based on Bis-Tris PAGE due to glycosylation. | Protein length : It contains Gly 25 – Thr 305 (HLA-A*0201),Ile21-Met119 (B2M) and SLLMWITQC peptide. | Endotoxin : Less than 0. 05EU per ug by the LAL method. | Purity : > 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC | Storage : The product should be stored at -70°C. Please do not repeated freeze-thaw cycles. | Reconstitution : It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4℃ before opening to recover the entire contents.